Your browser doesn't support javascript.
loading
Effect of epalrestat on diabetic peripheral neuropathy: a randomized placebo -controlled trails Meta-analysis / 中国基层医药
Article de Zh | WPRIM | ID: wpr-701689
Bibliothèque responsable: WPRO
ABSTRACT
Objective To assess the effect and safety of epalrestat on diabetic peripheral neuropathy ( DPN) . Methods Retrieved from PubMed,Cochrane Library,CNKI,VIP,CBM and Wanfang database ,RCTs about epalrestat in the treatment of DPN were included from establishment to July 2017 and comprehensively evaluated .Two reviewers independently screened literature according to the inclusion and exclusion criteria , extracted data , assessed the risk bias of included studies , and then analysis was performed using the RevMan 5.3 software.Results A total of 14 RCTs involved 1945 patients were included .The results of systematic review and Meta -analysis showed that epalrestat could significantly improve DPN compared with the placebo /blank control group ( OR =8.01,95%CI:4.48-14.32,P<0.01;OR=2.49,95%CI:1.71-3.65,P<0.01).Compared with the placebo group and the blank control group,epalrestat could significantly improve the median sensory nerve conduction velocity ( OR=3.92,95%Cl:1.37-6.47,P<0.01),peroneal nerve conduction velocity (OR=4.87,95%CI:2.35-7.39,P<0.01) and ulnar nerve conduction velocity ( OR =4.58, 95%CI:2.54-6.63, P <0.01 ).The major adverse reactions were gastrointestinal reactions ,nausea and vomiting ,but no serious adverse reactions were observed in the epalrestat group , compared with the placebo/blank control group,the difference was statistically significant (OR =12.87,95%CI:2.35-70.50,P<0.01).Conclusion Epalrestat can effectively treat DPN through improving the body's sensory nerve conduction velocity,and it has no serious adverse reactions .Since the limitation of quality and quantity of included studies,large-scale and high-quality randomized double -blinding controlled trails are needed to verify the above conclusion.
Mots clés
Texte intégral: 1 Indice: WPRIM Type d'étude: Clinical_trials / Systematic_reviews langue: Zh Texte intégral: Chinese Journal of Primary Medicine and Pharmacy Année: 2018 Type: Article
Texte intégral: 1 Indice: WPRIM Type d'étude: Clinical_trials / Systematic_reviews langue: Zh Texte intégral: Chinese Journal of Primary Medicine and Pharmacy Année: 2018 Type: Article